SEGMENT REPORTING (Tables)

12 Months Ended

Dec. 31, 2013

Schedule of Segment Reporting Information, by Segment Revenues [Table Text Block]

		Years Ended December 31,
		2013		2012
Revenues:
Chaoying Biotech	$	574,261	$	514,593
SD Chaoying		-		268,582
Others		-		-
Total Revenues	$	574,261	$	783,175

Schedule of Segment Reporting Information, by Segment Loss [Table Text Block]

		Years Ended December 31,
		2013		2012
Segment loss:
Chaoying Biotech	$	(62,734	$	(121,753
SD Chaoying		(334,939		(304,170
Others		(219,074		(229,717
Loss before Income Taxes	$	(616,747	$	(655,640

Schedule of Segment Reporting Information, by Segment Total Assets [Table Text Block]

		Years Ended December 31,
		2013		2012
Total Assets:
Chaoying Biotech	$	714,925	$	1,460,233
SD Chaoying		9,584,273		9,006,220
Others		53,544		85,055
Total assets	$	10,352,742	$	10,551,508

Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]

		Years Ended December 31,
		2013		2012
United States	$	417,082	$	450,042
China		157,179		333,133
Total revenue	$	574,261	$	783,175